gains (Page 2)

spawns Hutchmed (NASDAQ:HCM) ADRs traded higher on Friday after regulators in China agreed to review the company’s lymphoma therapy tazemetostat, developed and sold in partnership with Ipsen (OTCPK:IPSEY). China’s National Medical Products Administration (NMPA) granted priority review for the new drug application (NDA) targeting adults with relapsed or refractory (“R/R”)Continue Reading

Victor Golmer/iStock Editorial via Getty Images Grifols (NASDAQ:GRFS) shares traded higher on Friday after the Spanish plasma therapeutics company named Bank of America (BAC) executive Rahul Srinivasan, its new Chief Financial Officer (CFO). Srinivasan will assume duties effective September 16, 2024, replacing outgoing CFO Alfredo Arroyo, who recently announced hisContinue Reading

JHVEPhoto/iStock Editorial via Getty Images Smith & Nephew (NYSE:SNN) ADRs traded higher premarket Friday after the U.K.-based medical device maker disclosed an ownership stake from Swedish activist investor Cevian Capital. In a regulatory filing on Thursday, Smith & Nephew (SNN) said Cevian held a 5% stake in the London-listed firmContinue Reading